Action	Date	Notes	Link
article pdf uploaded.	5 June 2020 17:24 CEST	Version of Record	https://www.mdpi.com/2077-0383/9/6/1762/pdf-vor
article xml file uploaded	23 June 2020 09:15 CEST	Original file	-
article xml uploaded.	23 June 2020 09:15 CEST	Update	https://www.mdpi.com/2077-0383/9/6/1762/xml
article pdf uploaded.	23 June 2020 09:15 CEST	Updated version of record	https://www.mdpi.com/2077-0383/9/6/1762/pdf
article html file updated	23 June 2020 09:16 CEST	Original file	-
article html file updated	21 July 2022 20:04 CEST	Update	https://www.mdpi.com/2077-0383/9/6/1762/html

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Nakao, A.; Hiranuma, O.; Uchino, J.; Sakaguchi, C.; Araya, T.; Hiraoka, N.; Ishizuka, T.; Takeda, T.; Kawasaki, M.; Goto, Y.; et al. Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment. J. Clin. Med. 2020, 9, 1762. https://doi.org/10.3390/jcm9061762

AMA Style

Nakao A, Hiranuma O, Uchino J, Sakaguchi C, Araya T, Hiraoka N, Ishizuka T, Takeda T, Kawasaki M, Goto Y, et al. Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment. Journal of Clinical Medicine. 2020; 9(6):1762. https://doi.org/10.3390/jcm9061762

Chicago/Turabian Style

Nakao, Akira, Osamu Hiranuma, Junji Uchino, Chikara Sakaguchi, Tomoyuki Araya, Noriya Hiraoka, Tamotsu Ishizuka, Takayuki Takeda, Masayuki Kawasaki, Yasuhiro Goto, and et al. 2020. "Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment" Journal of Clinical Medicine 9, no. 6: 1762. https://doi.org/10.3390/jcm9061762

APA Style

Nakao, A., Hiranuma, O., Uchino, J., Sakaguchi, C., Araya, T., Hiraoka, N., Ishizuka, T., Takeda, T., Kawasaki, M., Goto, Y., Imai, H., Hattori, N., Nakatomi, K., Uramoto, H., Uryu, K., Fukuda, M., Uchida, Y., Yokoyama, T., Akai, M., ... Takayama, K. (2020). Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment. Journal of Clinical Medicine, 9(6), 1762. https://doi.org/10.3390/jcm9061762

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Printed Edition

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI